New York Psychiatric Institute — New York, New York

New York Psychiatric Institute is a clinical research site located in New York, New York, United States 10032.

Crixeo Health Trust Score: 62/100 (FAIR). This profile has not yet been claimed by the site owner.

New York Psychiatric Institute has participated in 3 clinical trials.

Therapeutic areas: Cannabis Use Disorder, Attention-deficit/Hyperactivity Disorder, Pathological Gambling.

Sponsors: New York State Psychiatric Institute, Braeburn Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 62/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for New York Psychiatric Institute?

New York Psychiatric Institute has a Crixeo Trust Score of 62/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has New York Psychiatric Institute conducted?

New York Psychiatric Institute has 3 clinical trials on record. Their work covers Cannabis Use Disorder, Attention-deficit/Hyperactivity Disorder, Pathological Gambling.

Is New York Psychiatric Institute accredited by Crixeo Health?

New York Psychiatric Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about New York Psychiatric Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.